Brazilian Journal of Anesthesiology
https://bjan-sba.org/article/doi/10.1590/S0034-70942002000100001
Brazilian Journal of Anesthesiology
Scientific Article

Concentração plasmática de ropivacaína durante anestesia peridural lombar em crianças

Ropivacaine and bupivacaine plasma concentration during lumbar epidural anesthesia in children

Verônica Vieira da Costa; Denise Pereira de Oliveira Souza; Marcelo Buzzi; Márcio Corrêa de Mello; Renato Ângelo Saraiva

http://dx.doi.org/10.1590/S0034-70942002000100001 Braz J Anesthesiol, vol.52, n1, p.1-8, 2002
PDF Português
PDF English
Downloads: 0
Views: 645

Resumo

JUSTIFICATIVA E OBJETIVOS: A ropivacaína é o mais novo anestésico local de uso na prática clínica. Sua estrutura é semelhante a forma levógira da bupivacaína, tendo portanto baixa toxicidade. Os valores das concentrações plasmáticas que podem ser atingidos em crianças, com o uso desta droga e também da bupivacaína (mesmo a forma racêmica) administradas por via peridural lombar, são ainda pouco conhecidos. O objetivo desse estudo foi avaliar as concentrações sangüíneas de ropivacaína e bupivacaína por via peridural lombar em crianças, em bloqueios eficientes, relacionando-as aos valores descritos como níveis plasmáticos seguros. MÉTODO: Oitenta e um pacientes de ambos os sexos, submetidos à cirurgia de membros inferiores, receberam aleatoriamente ropivacaína (n = 41) ou bupivacaína (n = 40) por via peridural lombar associado à anestesia geral. Foram coletadas oito amostras de sangue venoso nos intervalos de tempo: zero (controle), 5, 25, 40, 60, 120, 180 e 240 minutos, e através de cromatografia de gás foram dosadas as concentrações plasmáticas da ropivacaína e da bupivacaína. RESULTADOS: Não houve diferença estatisticamente significante com relação aos dados antropométricos e variáveis fisiológicas estudadas entre os pacientes que receberam ropivacaína e bupivacaína. As doses médias administradas de ropivacaína e bupivacaína foram 2,35 mg.kg-1 e 2,13 mg.kg-1, respectivamente, que geraram as concentrações plasmáticas de 2,334 µg.ml-1 e 1,111 µg.ml-1, aos 25 e 40 minutos. Ambas abaixo do nível considerado seguro (3 µg.kg-1). CONCLUSÕES: A administração peridural lombar de ropivacaína e bupivacaína em crianças, nas doses abaixo de 3 mg.kg-1, produz bloqueio anestésico eficaz e determina concentrações plasmáticas que podem ser consideradas seguras.

Palavras-chave

ANESTÉSICOS, Local, ANESTÉSICOS, Local, TÉCNICAS ANESTÉSICAS, Regional

Abstract

BACKGROUND AND OBJECTIVES: Ropivacaine is the newest local anesthetic drug for clinical practice. Its structure is similar to levogyrous bupivacaine, therefore exibiting low toxicity. Little is known about plasma concentrations that can be reached in children after lumbar epidural administration of these drugs (including racemic bupivacaine). The aim of this study was to evaluate ropivacaine and bupivacaine plasma concentrations following successful lumbar epidural blocks in children, correlating them to known safe plasma levels. METHODS: Eight-one children of both genders, aged between 2 and 16 year, scheduled to undergo lower limbs surgeries, were randomly divided in two groups to receive lumbar epidural ropivacaine ( n = 41) or bupivacaine (n = 40), associated to general anesthesia. Venous blood samples were collected at times 0 (control), 5, 25, 40, 60, 120, 180 and 240 minutes. Ropivacaine and bupivacaine plasma concentrations were measured by gas chromatography. RESULTS: There was no statistically significant difference in anthropometric and physiological variables between groups. Mean ropivacaine and bupivacaine doses were 2.35 mg.kg-1 and 2.13 mg.kg-1 respectively, leading to peak plasma concentrations of 2.334 µg.ml-1 and 1.111 µg.ml-1 at 25 and 40 minutes respectively, both below the safety level of 3 µg.ml-1. CONCLUSIONS: Lumbar epidural administration of ropivacaine and bupivacaine in children, in doses below 3 mg.kg-1, result in efficient anesthetic blocks and safe plasma concentrations.

Keywords

ANESTHETICS, Local, ANESTHETICS, Local, ANESTHETIC TECHNIQUES, Regional

References

McClure JH. Ropivacaine. Br J Anaesth. 1996;76:300-307.

Conceição MJ, Coelho L. Caudal anaesthesia with 0.375% ropivacaine or 0.375% bupivacaine in paediatric patients. Br J Anaesth. 1998;80:507-508.

Conceição MJ, Coelho L, Khalil M. Ropivacaine 0.25% compared with bupivacaine 0.25% by the caudal route. Paediatr Anaesth. 1999;92:229-233.

Habre W, Bergesio R, Johnson C. Plasma ropivacaine concentrations following caudal analgesia in children. Anesthesiology. 1998;89:AI245.

Habre W, Bergesio R, Johnson C. Pharmacokinetics of ropivacaine following caudal analgesia in children. Paediatr Anaesth. 2000;10:143-147.

Ivani G, Lampugnani E, De Negri P. Ropivacaine vs bupivacaine in major surgery in infants. Can J Anaesth. 1999;46:467-469.

Hansen TG, Ilett KF, Lim SI, Reid C. Pharmacokinetics and clinical efficacy of long-term epidural ropivacaine infusion in children. Br J Anaesth. 2000;85:347-353.

Scott DB, Lee A, Fagan D. Acute toxicity of ropivacaine compared with trat of bupivacaine. Anesth Analg. 1989;69:563-569.

Albright GA. Cardiac arrest following regional anesthesia with etidocaine and bupivacaine. Anesthesiology. 1979;51:285-287.

Arthur GR, Feldman HS, Covino BG. Comparative pharmacokinetics of bupivacaine and ropivacaine, a new amide local anesthetic. Anesth Analg. 1988;67:1053-1058.

Katz JA, Bridenbaugh PO, Knarr DC. Pharmacodynamics and pharmacokinetics of peridural ropivacaine in humans. Anesth Analg. 1990;70:16-21.

Morrison LMM, Emanuelsson BM, McClure JH. Efficacy and kinetics of extradural ropivacaine comparison with bupivacaine. Br J Anaesth. 1994;72:164-169.

Emanuelsson BMK, Person J, Alm C. Systemic absorption and block after epidural injection of ropivacaine in healthy volunteers. Anesthesiology. 1997;87:1309-1317.

Frawley G, Ragg P. Plasma concentrations of bupivacaine after combined spinal epidural anaesthesia in infants and neonates. Paediatr Anaesth. 2000;10:619-625.

Tahraoui A, Watson DG, Skellem GG. Comparative study of the determination of bupivacaine in human plasma by gas chromatography: mass spectrometry and high performance liquid chromatography. J Pharm Biomed Anal. 1996;15:251-257.

Nakamura K, Toda H, Kakuyama M. Direct vascular effect of ropivacaine in femoral artery and vein of the dog. Acta Anaesthesiol Scand. 1993;37:269-273.

Pitkanen M, Covino BG, Feldman HS. Chronotropic and inotropic effects of ropivacaine, bupivacaine, and lidocaine in the spontaneously beating and electrically paced isolated, perfused rabbit heart. Reg Anesth. 1992;17:183-192.

Feldman HS, Arthur GR, Covino BG. Comparative systemic toxicity of convulsant and supraconvulsant doses of intravenous ropivacaine, bupivacaine lidocaine in the conscious dog. Anesth Analg. 1989;69:794-801.

Tucher GT, Mather LE. Pharmacokinetics of local anaesthetic agents. Br J Anaesth. 1975;47:213-214.

Burm AGL, Vermeulen NPE, Van Kleef JW. Pharmacokinetics of lignocaine and bupivacaine in surgical patients following epidural administration: Simultaneous investigations of absorption and disposition kinetics using stable isotopes. Clin Pharmacokinet. 1979;13:191-203.

Tucker GT, Mather LE. Clinical pharmacokinetics of local anaesthetics. Clin Pharmacokinet. 1979;4:241-278.

Katz JÁ, Sehlhorst CS, Thompson GA. Pharmacokinetics of intravenous and epidural ropivacaine in the rhesus monkey. Biopharm Drug Disp. 1993;14:579-588.

Eyres RL, Hastings C, Brown TCK. Plasma bupivacaine concentrations following lumbar epidural anaesthesia in children. Anaesth Intensive Care. 1986;14:131-134.

Lee A, Fagan D, Lamont M. Disposition kinetics of ropivacaine in humans. Anesth Analg. 1989;69:736-738.

5dd599920e8825b809c8fca7 rba Articles
Links & Downloads
2352-2291 (Electronic) 0104-0014 (Printed)
Braz J Anesthesiol ©2024 All rights reserved.

Braz J Anesthesiol

Share this page
Page Sections